Senator Patrick Leahy, D-Vt., may have a tough time pushing through legislation to overturn the Supreme Court’s ruling last year that generic manufacturers cannot be held liable for inadequate label warnings. At least that is the view of Jay Lefkowitz, who represented generic manufacturers in that case, Pliva v. Mensing.
“I don’t think it’s likely to be a successful effort,” said Lefkowitz, a partner at Kirkland & Ellis. “It would...